96 related articles for article (PubMed ID: 7969185)
1. Acylation of the lipid A region of a Klebsiella pneumoniae LPS controls the alternative pathway activation of human complement.
Mey A; Ponard D; Colomb M; Normier G; Binz H; Revillard JP
Mol Immunol; 1994 Nov; 31(16):1239-46. PubMed ID: 7969185
[TBL] [Abstract][Full Text] [Related]
2. Activation of human monocyte chemiluminescence response by acylpoly(1,3)galactosides derived from Klebsiella pneumoniae.
Kouassi E; Hmama Z; Lina G; Vial J; Faure-Barba F; Normier G; Binz H; Revillard JP
J Leukoc Biol; 1992 Nov; 52(5):529-36. PubMed ID: 1431564
[TBL] [Abstract][Full Text] [Related]
3. Role of acyl residues in polyclonal murine B cell activation by acylpoly(1,3)galactosides from Klebsiella pneumoniae.
Hmama Z; Lina G; Normier G; Binz H; Revillard JP
J Immunol; 1993 Nov; 151(10):5440-9. PubMed ID: 8228237
[TBL] [Abstract][Full Text] [Related]
4. Monocyte cytokine secretion induced by chemically-defined derivatives of Klebsiella pneumoniae.
Hmama Z; Lina G; Vincent C; Wijdenes J; Normier G; Binz H; Revillard JP
Clin Exp Immunol; 1992 Jul; 89(1):104-9. PubMed ID: 1628418
[TBL] [Abstract][Full Text] [Related]
5. Binding to leukocytes and induction of TNF alpha production involve different sites within the lipid-A region of LPS-like molecules.
Mey A; Hmama Z; Normier G; Binz H; Revillard JP
Int J Immunopharmacol; 1994; 16(5-6):413-7. PubMed ID: 7927987
[TBL] [Abstract][Full Text] [Related]
6. Binding of a membrane proteoglycan from Klebsiella pneumoniae and its derivatives to human leukocytes.
Hmama Z; Normier G; Kouassi E; Flacher M; Binz H; Revillard JP
Immunobiology; 1992 Nov; 186(3-4):183-98. PubMed ID: 1490726
[TBL] [Abstract][Full Text] [Related]
7. Molecular basis for the increased polymyxin susceptibility of Klebsiella pneumoniae strains with under-acylated lipid A.
Velkov T; Soon RL; Chong PL; Huang JX; Cooper MA; Azad MA; Baker MA; Thompson PE; Roberts K; Nation RL; Clements A; Strugnell RA; Li J
Innate Immun; 2013 Jun; 19(3):265-77. PubMed ID: 23008349
[TBL] [Abstract][Full Text] [Related]
8. Binding of a bacterial acylpoly(1,3)galactoside to human blood leucocytes.
Hmama Z; Kouassi E; Panaye G; Delassan S; Normier G; Binz H; Revillard JP
Scand J Immunol; 1992 Jul; 36(1):11-20. PubMed ID: 1615280
[TBL] [Abstract][Full Text] [Related]
9. CD14 and CD11b mediate serum-independent binding to human monocytes of an acylpolygalactoside isolated from Klebsiella pneumoniae.
Hmama Z; Mey A; Normier G; Binz H; Revillard JP
Infect Immun; 1994 May; 62(5):1520-7. PubMed ID: 7513300
[TBL] [Abstract][Full Text] [Related]
10. Alteration of dealcylated lipopolysaccharide antagonistic properties by interaction with plasma factors.
Mey A; Hmama Z; Normier G; Revillard JP
J Leukoc Biol; 1997 Jan; 61(1):17-23. PubMed ID: 9000532
[TBL] [Abstract][Full Text] [Related]
11. Complement activating property of the protein-rich endotoxin (OEP) of Pseudomonas aeruginosa. II. Complement activating property of the lipopolysaccharide portion and the inhibition by polymyxin B.
Inada K
Jpn J Exp Med; 1980 Apr; 50(2):107-15. PubMed ID: 6256561
[TBL] [Abstract][Full Text] [Related]
12. Activation of human serum complement by bacterial lipopolysaccharides: structural requirements for antibody independent activation of the classical and alternative pathways.
Vukajlovich SW; Hoffman J; Morrison DC
Mol Immunol; 1987 Apr; 24(4):319-31. PubMed ID: 3309624
[TBL] [Abstract][Full Text] [Related]
13. Complement activating property of the protein-rich endotoxin (OEP) of Pseudomonas aeruginosa. I. Activation of both the classical and the alternative pathways of guinea pig complement.
Inada K
Jpn J Exp Med; 1980 Feb; 50(1):13-21. PubMed ID: 6770130
[TBL] [Abstract][Full Text] [Related]
14. Secondary acylation of Klebsiella pneumoniae lipopolysaccharide contributes to sensitivity to antibacterial peptides.
Clements A; Tull D; Jenney AW; Farn JL; Kim SH; Bishop RE; McPhee JB; Hancock RE; Hartland EL; Pearse MJ; Wijburg OL; Jackson DC; McConville MJ; Strugnell RA
J Biol Chem; 2007 May; 282(21):15569-77. PubMed ID: 17371870
[TBL] [Abstract][Full Text] [Related]
15. Strong interaction of lipopolysaccharides possessing the mannose homopolysaccharides with complement and its relation to adjuvant action.
Yokochi T; Inoue Y; Kimura Y; Kato N
J Immunol; 1990 Apr; 144(8):3106-10. PubMed ID: 2182713
[TBL] [Abstract][Full Text] [Related]
16. Evidence for different requirements in physical state for the interaction of lipopolysaccharides with the classical and alternative pathways of complement.
Wilson ME; Morrison DC
Eur J Biochem; 1982 Nov; 128(1):137-41. PubMed ID: 6756918
[TBL] [Abstract][Full Text] [Related]
17. Effect of Haemophilus influenzae type b lipopolysaccharide on complement activation and polymorphonuclear leukocyte function.
Inzana TJ; Tosi MF; Kaplan SL; Anderson DC; Mason EO; Williams RP
Pediatr Res; 1987 Dec; 22(6):659-66. PubMed ID: 3324033
[TBL] [Abstract][Full Text] [Related]
18. Antibody-independent activation of the classical pathway of human serum complement by lipid A is restricted to re-chemotype lipopolysaccharide and purified lipid A.
Vukajlovich SW
Infect Immun; 1986 Sep; 53(3):480-5. PubMed ID: 3744547
[TBL] [Abstract][Full Text] [Related]
19. Lethal effect of complement and lysozyme on polymyxin-treated, serum-resistant gram-negative bacilli.
Fierer J; Finley F
J Infect Dis; 1979 Oct; 140(4):581-9. PubMed ID: 229175
[TBL] [Abstract][Full Text] [Related]
20. Activation of the classical and properdin pathways of complement by bacterial lipopolysaccharides (LPS).
Morrison DC; Kline LF
J Immunol; 1977 Jan; 118(1):362-8. PubMed ID: 318670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
